Myasthenia gravis: understanding treatment patterns and direct medical costs in the Czech Republic
Abstract Background Myasthenia gravis (MG) is a rare autoimmune disorder with significant clinical implications, including life-threatening myasthenic crises and exacerbations. Understanding real-world treatment patterns, especially associated direct medical costs, is essential for the effective man...
Главные авторы: | Gleb Donin, Karla Mothejlová, Magda Horáková, Stanislav Vohanka |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
BMC
2024-12-01
|
Серии: | Orphanet Journal of Rare Diseases |
Предметы: | |
Online-ссылка: | https://doi.org/10.1186/s13023-024-03504-3 |
Схожие документы
-
Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry
по: Stanislav Voháňka, и др.
Опубликовано: (2024-12-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
по: E. D. Gasymly
Опубликовано: (2018-06-01) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
по: Courtney Townsel, и др.
Опубликовано: (2016-03-01) -
Pregnancy with Myasthenia Gravis
по: Ninuk Dwi ariningtyas, и др.
Опубликовано: (2020-01-01) -
Delayed diagnosis of distal myasthenia gravis: a case report
по: M. L. Cao, и др.
Опубликовано: (2024-11-01)